Evaxion Biotech (EVAX) Tops Q2 EPS by 10c
Evaxion Biotech (NASDAQ: EVAX) reported Q2 EPS of ($0.20), $0.10 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.
Evaxion Biotech (NASDAQ: EVAX) reported Q2 EPS of ($0.20), $0.10 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Evaxion Biotech (EVAX) click here.